 NEW YORK, Dec. 16, 2022 GLOBE NEWSWIRE Bragar Eagel Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals, Inc. EyePoint or the Company NASDAQ: EYPT on behalf of EyePoint stockholders. Our investigation concerns whether EyePoint has violated the federal securities laws andor engaged in other unlawful ... The post EYEPOINT ALERT: Bragar Eagel Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc... 